沙特阿拉伯潜伏性结核感染检测与治疗指南。
Saudi guidelines for testing and treatment of latent tuberculosis infection.
作者信息
Al Jahdali Hamdan H, Baharoon Salim, Abba Abdullah A, Memish Ziad A, Alrajhi Abdulrahman A, AlBarrak Ali, Haddad Qais A, Al Hajjaj Mohammad, Pai Madhukar, Menzies Dick
机构信息
Department of Medicine, King Saud University for Health Sciences, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
出版信息
Ann Saudi Med. 2010 Jan-Feb;30(1):38-49. doi: 10.4103/0256-4947.59373.
Abstract
Pulmonary tuberculosis is a common disease in Saudi Arabia. As most cases of tuberculosis are due to reactivation of latent infection, identification of individuals with latent tuberculosis infection (LTBI) who are at increased risk of progression to active disease, is a key element of tuberculosis control programs. Whereas general screening of individuals for LTBI is not cost-effective, targeted testing of individuals at high risk of disease progression is the right approach. Treatment of those patients with LTBI can diminish the risk of progression to active tuberculosis disease in the majority of treated patients. This statement is the first Saudi guideline for testing and treatment of LTBI and is a result of the cooperative efforts of four local Saudi scientific societies. This Guideline is intended to provide physicians and allied health workers in Saudi Arabia with the standard of care for testing and treatment of LTBI.
摘要
肺结核在沙特阿拉伯是一种常见疾病。由于大多数结核病病例是由潜伏感染的重新激活引起的，识别那些有进展为活动性疾病风险增加的潜伏性结核感染（LTBI）个体，是结核病控制项目的关键要素。虽然对个体进行LTBI的普遍筛查不具有成本效益，但对疾病进展高风险个体进行有针对性的检测是正确的方法。对这些LTBI患者进行治疗可以降低大多数接受治疗患者进展为活动性结核病的风险。本声明是沙特阿拉伯关于LTBI检测和治疗的首个指南，是沙特四个当地科学协会合作努力的成果。本指南旨在为沙特阿拉伯的医生和相关医护人员提供LTBI检测和治疗的护理标准。
相似文献
1
Saudi guidelines for testing and treatment of latent tuberculosis infection.
Ann Saudi Med. 2010 Jan-Feb;30(1):38-49. doi: 10.4103/0256-4947.59373.
2
Compliance with postexposure screening and treatment of latent tuberculosis infection among healthcare workers in a tertiary care hospital in Saudi Arabia.
Infect Control Hosp Epidemiol. 2014 Feb;35(2):176-81. doi: 10.1086/674855. Epub 2013 Dec 13.
3
Screening of latent tuberculosis infection among health care workers working in Hajj pilgrimage area in Saudi Arabia, using interferon gamma release assay and tuberculin skin test.
Ann Saudi Med. 2018 Mar-Apr;38(2):90-96. doi: 10.5144/0256-4947.2018.90.
4
National position statement for the management of latent tuberculosis infection.
Commun Dis Intell Q Rep. 2017 Sep 1;41(3):E204-E208.
5
Latent tuberculosis infection among health-care workers using Quantiferon-TB Gold-Plus in a country with a low burden for tuberculosis: prevalence and risk factors.
Ann Saudi Med. 2020 May-Jun;40(3):191-199. doi: 10.5144/0256-4947.2020.191. Epub 2020 Jun 4.
6
Tuberculosis in Saudi Arabia: can we change the way we deal with the disease?
J Infect Public Health. 2010;3(1):17-24. doi: 10.1016/j.jiph.2009.12.001. Epub 2010 Feb 16.
7
A prospective cohort study of latent tuberculosis in adult close contacts of active pulmonary tuberculosis patients in Korea.
Korean J Intern Med. 2016 May;31(3):517-24. doi: 10.3904/kjim.2015.095. Epub 2016 Apr 7.
8
Tuberculosis among asylum seekers in Milan, Italy: epidemiological analysis and evaluation of interventions.
Eur Respir J. 2019 Oct 31;54(4). doi: 10.1183/13993003.00896-2019. Print 2019 Oct.
9
Prevalence of Latent Mycobacterium Tuberculosis Infection (LTBI) in Saudi Arabia; Population based survey.
Int J Infect Dis. 2017 Jul;60:11-16. doi: 10.1016/j.ijid.2017.03.024. Epub 2017 Apr 6.
10
Pre-employment screening of latent tuberculosis infection among healthcare workers using tuberculin skin test and QuantiFERON-TB Gold test at a tertiary care hospital in Saudi Arabia.
J Infect Public Health. 2014 Nov-Dec;7(6):481-8. doi: 10.1016/j.jiph.2014.07.012. Epub 2014 Sep 4.
引用本文的文献
1
Magnitude and Determinants of Latent Tuberculosis Among Inmates of Saudi Correctional Facilities: A Cross-Sectional Study.
Int J Gen Med. 2024 Oct 2;17:4475-4483. doi: 10.2147/IJGM.S472710. eCollection 2024.
2
Technical Quality and Diagnostic Impact of Chest X-rays in Tuberculosis Screening: Insights From a Saudi Teleradiology Cohort.
Cureus. 2024 Feb 3;16(2):e53509. doi: 10.7759/cureus.53509. eCollection 2024 Feb.
3
Knowledge, attitude and practice towards tuberculosis among healthcare and non-healthcare students at a public university in Saudi Arabia.
Front Public Health. 2024 Feb 5;12:1348975. doi: 10.3389/fpubh.2024.1348975. eCollection 2024.
4
Monitoring the effect of TNF-alpha inhibitors on laboratory parameters and adverse effects in different diseases: a retrospective, single-center study.
Ann Saudi Med. 2022 Sep-Oct;42(5):309-318. doi: 10.5144/0256-4947.2022.309. Epub 2022 Oct 6.
5
The risk of tuberculosis infection in 410 Saudipatients receiving adalimumab therapy.
Ann Saudi Med. 2021 Sep-Oct;41(5):285-292. doi: 10.5144/0256-4947.2021.285. Epub 2021 Oct 7.
6
Prevalence of Latent Tuberculosis Infection Among Healthy Young Children and Adolescents and a Two-step Approach for the Diagnosis of Tuberculosis Infection in Chengdu, China.
Pediatr Infect Dis J. 2022 Jan 1;41(1):6-11. doi: 10.1097/INF.0000000000003338.
7
Assessing the Quality of Clinical Practice Guidelines in the Middle East and North Africa (MENA) Region: A Systematic Review.
J Multidiscip Healthc. 2021 Feb 9;14:297-309. doi: 10.2147/JMDH.S284689. eCollection 2021.
8
Incidence of latent tuberculosis infection among health science students during clinical training.
Ann Thorac Med. 2020 Jan-Mar;15(1):33-37. doi: 10.4103/atm.ATM_230_19. Epub 2020 Jan 2.
9
Screening and prevention for latent tuberculosis in immunosuppressed patients at risk for tuberculosis: a systematic review of clinical practice guidelines.
BMJ Open. 2018 Sep 12;8(9):e022445. doi: 10.1136/bmjopen-2018-022445.
10
Screening of latent tuberculosis infection among health care workers working in Hajj pilgrimage area in Saudi Arabia, using interferon gamma release assay and tuberculin skin test.
Ann Saudi Med. 2018 Mar-Apr;38(2):90-96. doi: 10.5144/0256-4947.2018.90.
本文引用的文献
1
LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement.
Eur Respir J. 2009 May;33(5):956-73. doi: 10.1183/09031936.00120908.
2
Within-subject variability and boosting of T-cell interferon-gamma responses after tuberculin skin testing.
Am J Respir Crit Care Med. 2009 Jul 1;180(1):49-58. doi: 10.1164/rccm.200811-1704OC. Epub 2009 Apr 2.
3
Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update.
Ann Intern Med. 2008 Aug 5;149(3):177-84. doi: 10.7326/0003-4819-149-3-200808050-00241. Epub 2008 Jun 30.
4
Species spectrum of nontuberculous mycobacteria isolated from clinical specimens in Kuwait.
Curr Microbiol. 2008 May;56(5):413-7. doi: 10.1007/s00284-008-9102-3. Epub 2008 Jan 30.
5
Prevalence of tuberculosis infection in the United States population: the national health and nutrition examination survey, 1999-2000.
Am J Respir Crit Care Med. 2008 Feb 1;177(3):348-55. doi: 10.1164/rccm.200701-057OC. Epub 2007 Nov 7.
6
Safety of treatment of latent tuberculosis infection in compensated cirrhotic patients during transplant candidacy period.
Transplantation. 2007 Jun 27;83(12):1557-62. doi: 10.1097/01.tp.0000266578.45634.4f.
7
T-cell assays for the diagnosis of latent tuberculosis infection: moving the research agenda forward.
Lancet Infect Dis. 2007 Jun;7(6):428-38. doi: 10.1016/S1473-3099(07)70086-5.
8
Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research.
Ann Intern Med. 2007 Mar 6;146(5):340-54. doi: 10.7326/0003-4819-146-5-200703060-00006.
9
Risk of tuberculosis in dialysis patients: association of tuberculin and 2,4-dinitrochlorobenzene reactivity with risk of tuberculosis.
Int Urol Nephrol. 2006;38(3-4):745-51. doi: 10.1007/s11255-006-9051-3.
10
False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria?
Int J Tuberc Lung Dis. 2006 Nov;10(11):1192-204.
Zotero 插件